Company Description

A biotechnology company dedicated to the R&D, manufacturing and commercialization of vaccine products for human use.

Tianjin CanSino Biotechnology Inc. (CanSino) is a biotechnology company dedicated to the R&D, manufacturing and commercialization of vaccine products for human use. The company was founded in Tianjin Economic and Technological Development Area (TEDA) in 2009. The founding party of CanSino consist of scientists and managers who have previously held senior management and technical positions in some of the world’s leading pharmaceutical companies. The management team has a proven track record of success in new drug discovery, development and commercialization. In addition, CanSino’s scientific advisory board is comprised of internationally recognized senior executives and leading members of academia who provide unique and complementary insights to guide the company’s growth.